Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Policy-makers must decide: Cover uninsured or pay a higher price

    There is a money available to subsidize health insurance for the uninsured, but it needs to come from money spent on uncompensated treatment, says a report presented by a coalition of groups looking to improve insurance coverage.
  • Full May 2003 Issue in PDF

  • From Stingers to Fangs: Evaluating and Managing Bites and Envenomations

    Whether a bite or sting results in an anaphylactic reaction, impressive local effects, or a life-threatening systemic reaction, the emergency physician must be able to institute appropriate and effective treatment. Emergency physicians also must be able to recognize clinical envenomation patterns, since some critically ill patients may not be able to convey the details of the attack. Since all areas of the country are represented in the envenomation statistics, all emergency physicians should be familiar with identification and stabilization of envenomated patients and know what resources are available locally for further management of these often complicated patients.
  • Acquisitions

    CardioTech International (Woburn, Massachusetts) said it would complete the acquisition of Gish Biomedical (Rancho Santa Margarita, California) by April 7. The value of the stock-for-stock deal has not been disclosed.
  • Report from Europe

    The explosion of Internet-based advertising for genetic tests has provoked a sharp reaction from the European Unions top advisers on ethics. They issued a call for caution last month and promised to investigate the matter closely.
  • Full April 1, 2003 Issue in PDF

  • Personnel File

    Todd Schermerhorn has been named senior vice president and chief financial officer of C.R. Bard (Murray Hill, New Jersey), replacing Charles Slacik, who has resigned.
  • From the Lab

    With the salient risk factor for development of cardiovascular disease being advancing old age, research cardiologist Roger Hajjar notes that efforts to develop gene therapy for heart disease have been geared toward the elderly, since they have fewer therapeutic options.
  • Ischemic stroke focus is on widening the therapeutic window

    PHOENIX, Arizona Ischemic stroke accounts for 80% to 85% of the estimated 750,000 strokes that occur annually in the U.S. Thus, it was no surprise that at this years International Stroke Conference, sponsored annually by the American Heart Association (Dallas, Texas) and held here in February, issues and developments related to ischemic stroke were in the limelight.
  • Healthcare system searches for solutions to costs, other problems

    IRVINE, California Inefficiencies, inequities, escalating costs and issues of access within the U.S. healthcare system have continued to challenge both the public and private sectors for well over a decade.